http://www.unboundmedicine.com/medline/ebm/research/cladribineUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19921304/full_citation/Development_of_oral_cladribine_for_the_treatment_of_multiple_sclerosis_Hartung HP, Aktas O, Kieseier B, et al. 
Development of oral cladribine for the treatment of multiple sclerosis. [JOURNAL ARTICLE]
J Neurol 2009 Nov 18.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19911856/full_citation/Current_and_emerging_treatments_for_chronic_lymphocytic_leukaemia_Robak T, Jamroziak K, Robak P 
Current and emerging treatments for chronic lymphocytic leukaemia. [Journal Article]
Drugs 2009; 69(17):2415-49.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19911397/full_citation/R_roscovitine__Seliciclib__affects_CLL_cells_more_strongly_than_combinations_of_fludarabine_or_cladribine_with_cyclophosphamide:_Inhibition_of_CDK7_sensitizes_leukemic_cells_to_caspase_dependent_apoptosis_Rogalińska M, Błoński JZ, Komina O, et al. 
R-roscovitine (Seliciclib) affects CLL cells more strongly than combinations of fludarabine or cladribine with cyclophosphamide: Inhibition of CDK7 sensitizes leukemic cells to caspase-dependent apoptosis. [JOURNAL ARTICLE]
J Cell Biochem 2009 Nov 12.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19907111/full_citation/Cladribine_treatment_in_two_hour_intravenous_infusion_for_previously_treated_low_grade_B_cell_lymphoma:_a_pilot_study_Takamatsu Y, Suzumiya J, Ogata K, et al. 
Cladribine treatment in two-hour intravenous infusion for previously-treated low grade B-cell lymphoma: a pilot study. [Journal Article, Research Support, Non-U.S. Gov't]
J Clin Exp Hematop 2009 Nov; 49(2):69-75.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19882371/full_citation/New_oral_drugs_for_multiple_sclerosis_Gasperini C, Ruggieri S 
New oral drugs for multiple sclerosis. [Journal Article]
Neurol Sci 2009 Oct.:S179-83.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19885837/full_citation/Combination_of_cladribine_plus_topotecan_for_recurrent_or_refractory_pediatric_acute_myeloid_leukemia_Inaba H, Stewart CF, Crews KR, et al. 
Combination of cladribine plus topotecan for recurrent or refractory pediatric acute myeloid leukemia. [JOURNAL ARTICLE]
Cancer 2009 Nov 2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19814696/full_citation/Approach_to_the_patient_after_relapse_of_hairy_cell_leukemia_Kreitman RJ, Fitzgerald DJ, Pastan I 
Approach to the patient after relapse of hairy cell leukemia. [Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't]
Leuk Lymphoma 2009 Oct.:32-7.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19814694/full_citation/Long_term_follow_up_studies_in_hairy_cell_leukemia_Grever MR, Zinzani PL 
Long-term follow-up studies in hairy cell leukemia. [Journal Article]
Leuk Lymphoma 2009 Oct.:23-6.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19814693/full_citation/Combination_therapies_to_improve_the_long_term_outcome_in_hairy_cell_leukemia_Lauria F, Forconi F 
Combination therapies to improve the long-term outcome in hairy cell leukemia. [Journal Article]
Leuk Lymphoma 2009 Oct.:18-22.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19814692/full_citation/Cladribine_in_the_treatment_of_hairy_cell_leukemia:_initial_and_subsequent_results_Huynh E, Sigal D, Saven A 
Cladribine in the treatment of hairy cell leukemia: initial and subsequent results. [Journal Article]
Leuk Lymphoma 2009 Oct.:12-7.
Abstract | Full Citation | Find Related Articles